EQS-News: innoscripta reports successful third quarter of 2025
Werte in diesem Artikel
|
EQS-News: innoscripta SE
/ Key word(s): Miscellaneous
Werbung Werbung Munich, November 3, 2025 – innoscripta SE (ISIN: DE000A40QVM8, “the Company”), a leading provider of cloud-based software solutions for tax incentives for research and development (R&D) in Germany, publishes its results for the third quarter of 2025.
In the third quarter of 2025, the Company further increased its revenue and earnings: * Consolidated revenue: €70.7 million (Q3/2024: €39.2 million) à +80.3% * Consolidated EBIT: €40.8 million (Q3/2024: €20.8 million) à +96.3% * Consolidated EBIT margin: 57.8% (Q3/2024: 53.1%) * Consolidated net income after taxes: €27.9 million (Q3/2024: €14.0 million) à +98.6% This growth was achieved in particular through the optimization of digital processes, the continuous development of the Clusterix platform, and the targeted expansion of scalability and efficiency. The complete Q3 2025 figures are available for download in the “Investors” section of the company website.
03.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | innoscripta SE |
| Arnulfstraße 60 | |
| 80335 München | |
| Germany | |
| Phone: | +4989262004187 |
| E-mail: | info@innoscripta.com |
| Internet: | https://www.innoscripta.com |
| ISIN: | DE000A40QVM8 |
| WKN: | A40QVM |
| Listed: | Regulated Unofficial Market in Dusseldorf, Frankfurt (Scale), Munich, Tradegate Exchange |
| EQS News ID: | 2222328 |
| End of News | EQS News Service |
|
|
2222328 03.11.2025 CET/CEST
Ausgewählte Hebelprodukte auf innoscripta
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf innoscripta
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu innoscripta SE Inhaber-Akt
Analysen zu innoscripta SE Inhaber-Akt
Keine Analysen gefunden.